A detailed history of Advisors Asset Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 83,068 shares of NVO stock, worth $9.89 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
83,068
Previous 68,100 21.98%
Holding current value
$9.89 Million
Previous $8.74 Million 35.6%
% of portfolio
0.24%
Previous 0.17%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $1.84 Million - $2.2 Million
14,968 Added 21.98%
83,068 $11.9 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $1.74 Million - $2.32 Million
17,035 Added 33.36%
68,100 $8.74 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $2.83 Million - $3.4 Million
32,283 Added 171.88%
51,065 $5.28 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $534,543 - $591,671
3,427 Added 22.32%
18,782 $3.04 Million
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $54,524 - $65,565
412 Added 2.76%
15,355 $2.44 Million
Q3 2022

Nov 08, 2022

BUY
$95.28 - $116.93 $25,725 - $31,571
270 Added 2.9%
9,596 $956,000
Q2 2022

Aug 08, 2022

BUY
$103.24 - $121.81 $290,723 - $343,016
2,816 Added 43.26%
9,326 $1.04 Million
Q1 2022

May 17, 2022

SELL
$93.1 - $112.54 $121,774 - $147,202
-1,308 Reduced 16.73%
6,510 $723,000
Q4 2021

Feb 15, 2022

SELL
$95.88 - $117.08 $55,610 - $67,906
-580 Reduced 6.91%
7,818 $876,000
Q3 2021

Nov 12, 2021

BUY
$84.42 - $106.62 $47,275 - $59,707
560 Added 7.14%
8,398 $806,000
Q2 2021

Jul 30, 2021

BUY
$67.66 - $84.76 $78,147 - $97,897
1,155 Added 17.28%
7,838 $657,000
Q1 2021

May 07, 2021

BUY
$67.06 - $75.82 $103,339 - $116,838
1,541 Added 29.97%
6,683 $451,000
Q4 2020

Feb 12, 2021

SELL
$63.89 - $73.8 $57,501 - $66,420
-900 Reduced 14.9%
5,142 $359,000
Q3 2020

Nov 16, 2020

BUY
$63.69 - $70.22 $20,571 - $22,681
323 Added 5.65%
6,042 $419,000
Q2 2020

Aug 12, 2020

SELL
$58.54 - $67.94 $59,769 - $69,366
-1,021 Reduced 15.15%
5,719 $374,000
Q1 2020

May 15, 2020

SELL
$49.46 - $64.78 $286,966 - $375,853
-5,802 Reduced 46.26%
6,740 $406,000
Q4 2019

Feb 14, 2020

SELL
$49.86 - $58.26 $83,714 - $97,818
-1,679 Reduced 11.81%
12,542 $726,000
Q3 2019

Nov 14, 2019

SELL
$47.54 - $53.43 $308,772 - $347,027
-6,495 Reduced 31.35%
14,221 $735,000
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $42,251 - $47,380
903 Added 4.56%
20,716 $1.06 Million
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $64,996 - $73,787
1,402 Added 7.62%
19,813 $1.04 Million
Q4 2018

Jan 31, 2019

BUY
$41.54 - $47.25 $73,484 - $83,585
1,769 Added 10.63%
18,411 $848,000
Q3 2018

Nov 15, 2018

SELL
$46.76 - $51.24 $26,840 - $29,411
-574 Reduced 3.33%
16,642 $785,000
Q2 2018

Aug 22, 2018

SELL
$44.29 - $50.42 $7.09 Million - $8.07 Million
-160,105 Reduced 90.29%
17,216 $794,000
Q2 2018

Aug 15, 2018

BUY
$44.29 - $50.42 $7.41 Million - $8.44 Million
167,340 Added 1676.59%
177,321 $794,000
Q1 2018

May 15, 2018

BUY
$48.49 - $58.14 $9,649 - $11,569
199 Added 2.03%
9,981 $514,000
Q4 2017

Feb 13, 2018

BUY
$47.53 - $53.73 $123,625 - $139,751
2,601 Added 36.22%
9,782 $525,000
Q3 2017

Nov 07, 2017

BUY
$41.15 - $49.22 $295,498 - $353,448
7,181
7,181 $346,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $269B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.